OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis For Up to 3 Years
April W. Armstrong, Mark Lebwohl, Richard B. Warren, et al.
JAMA Dermatology (2024)
Open Access | Times Cited: 6
April W. Armstrong, Mark Lebwohl, Richard B. Warren, et al.
JAMA Dermatology (2024)
Open Access | Times Cited: 6
Showing 6 citing articles:
Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO ‐1, PSO ‐4, and LTE trials
Akimichi Morita, Shinichi Imafuku, Yayoi Tada, et al.
The Journal of Dermatology (2025)
Open Access | Times Cited: 1
Akimichi Morita, Shinichi Imafuku, Yayoi Tada, et al.
The Journal of Dermatology (2025)
Open Access | Times Cited: 1
Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials
April W. Armstrong, Leon Kircik, Linda Stein Gold, et al.
Dermatology and Therapy (2025)
Open Access
April W. Armstrong, Leon Kircik, Linda Stein Gold, et al.
Dermatology and Therapy (2025)
Open Access
Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Japanese Patients With Plaque Psoriasis: In‐Depth Analysis of Efficacy and Safety in the Phase 3 POETYK PSO ‐4 Trial
Yukari Okubo, Akimichi Morita, Shinichi Imafuku, et al.
The Journal of Dermatology (2025)
Open Access
Yukari Okubo, Akimichi Morita, Shinichi Imafuku, et al.
The Journal of Dermatology (2025)
Open Access
Deucravacitinib: Adverse Events of Interest Across Phase 3 Plaque Psoriasis Trials
Joseph F. Merola, Laura K. Ferris, Jeffrey M. Sobell, et al.
Dermatology and Therapy (2025)
Open Access
Joseph F. Merola, Laura K. Ferris, Jeffrey M. Sobell, et al.
Dermatology and Therapy (2025)
Open Access
The Expanding Therapeutic Potential of Deucravacitinib Beyond Psoriasis: A Narrative Review
Chul Hwan Bang, Chul Jong Park, Yoon‐Seob Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1745-1745
Open Access
Chul Hwan Bang, Chul Jong Park, Yoon‐Seob Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1745-1745
Open Access
Exploring the Efficacy, Safety, and Clinical Implications of Deucravacitinib in East Asians with Psoriasis: A Narrative Review
Chul Hwan Bang, Chul Jong Park, Yoon‐Seob Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1746-1746
Open Access
Chul Hwan Bang, Chul Jong Park, Yoon‐Seob Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1746-1746
Open Access
Bullous Pemphigoid Overlapping Psoriasis Vulgaris: A Rare Case Report and Literature Review
Maria-Alexandra Timofte, Constantin Căruntu, Beatrice Bălăceanu-Gurău, et al.
Clinics and Practice (2025) Vol. 15, Iss. 5, pp. 91-91
Open Access
Maria-Alexandra Timofte, Constantin Căruntu, Beatrice Bălăceanu-Gurău, et al.
Clinics and Practice (2025) Vol. 15, Iss. 5, pp. 91-91
Open Access
